Cargando…
Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up
Background: A recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), which began in Wuhan, China, with a high level of human-to-human transmission has been reported. There are limited data available on Coronavirus Disease 2019 (COVID-19) patients with hematological malignan...
Autores principales: | Ye, Xingnong, Xiao, Xiaofang, Li, Bin, Zhu, Weigang, Li, Youjiang, Wu, Jianguo, Huang, Xin, Jin, Jingxia, Chen, Dan, Jin, Jie, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348056/ https://www.ncbi.nlm.nih.gov/pubmed/32719750 http://dx.doi.org/10.3389/fonc.2020.01272 |
Ejemplares similares
-
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022) -
Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022) -
NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023) -
BCOR mutation and TLS-ERG expression in acute myeloid leukemia with monoclonal immunoglobulinemia
por: Jin, Jingxia, et al.
Publicado: (2019) -
Editorial: Biology and treatment of high-risk CLL
por: Tausch, Eugen, et al.
Publicado: (2023)